• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP CARCINOEMBRYONIC ANTIGEN (CEA); SYSTEM, TEST, CARCINOEMBRYONIC ANTIGEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP CARCINOEMBRYONIC ANTIGEN (CEA); SYSTEM, TEST, CARCINOEMBRYONIC ANTIGEN Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/24/2022
Event Type  malfunction  
Manufacturer Narrative
An outside of the united states (ous) customer contacted a siemens customer care center (ccc) and reported a falsely depressed carcinoembryonic antigen (cea) patient sample result that was obtained on an advia centaur cp instrument.The result was considered to be discordant with the repeat testing on the same instrument and on the advia centaur xpt at an alternate site.Siemens is investigating the issue.The limitations section of the instructions for use states: "note: do not interpret levels of cea as absolute evidence of the presence or the absence of malignant disease.Measurements of cea should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation.".
 
Event Description
A falsely depressed carcinoembryonic antigen (cea) result was obtained on a patient sample on an advia centaur cp instrument.The falsely depressed result was not reported to the physician(s).On the following day, (b)(6) 2022, the sample was repeated at an alternate lab on an advia centaur xpt instrument.The sample was then diluted 1:10 and repeated on the initial instrument.The result was higher than the initial discordant result.On (b)(6) 2022, the sample was repeated on the initial instrument and the result recovered at >100 ng/ml.The repeat result from the alternate instrument was reported as the correct result, to the physician.The higher results were considered correct.There are no known reports of patient intervention or adverse health consequences due to the falsely depressed cea result.
 
Manufacturer Narrative
The initial mdr 1219913-2022-00153 was filed on may 20, 2022.Additional information - june 3, 2022: an outside of the united states (ous) customer contacted a siemens customer care center (ccc) and reported a falsely depressed carcinoembryonic antigen (cea) patient sample result that was obtained on an advia centaur cp instrument.The result was considered to be discordant with the repeat testing on the same instrument and on the advia centaur xpt at an alternate site.The sample recovered 90.4 ng/ml when tested with advia centaur cp carcinoembryonic antigen (cea) kit lot 209 but when tested at another lab the advia centaur xpt cea result was 510 ng/ml.When the sample was repeated at the customer site undiluted it recovered >100 ng/ml and when diluted 1/10 with an unknown liquid, not cea diluent, the result was 584 ng/ml after being corrected for the dilution.The patient had high results for bilirubin and liver enzymes but values were not provided.Siemens reviewed the control data provided and there is no evidence of a problem.Based on the information available, no product problem was identified.In section h6, the investigation finding, and investigation conclusion codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR CP CARCINOEMBRYONIC ANTIGEN (CEA)
Type of Device
SYSTEM, TEST, CARCINOEMBRYONIC ANTIGEN
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
7818564812
MDR Report Key14466094
MDR Text Key300354178
Report Number1219913-2022-00153
Device Sequence Number1
Product Code DHX
UDI-Device Identifier00630414177304
UDI-Public00630414177304
Combination Product (y/n)N
Reporter Country CodeEG
PMA/PMN Number
K200215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/21/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/19/2022
Device Model NumberN/A
Device Catalogue Number10309977
Device Lot Number209
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/28/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-